93
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Application of Ion Exchange Resin in Floating Drug Delivery System

, , &
Pages 1117-1124 | Published online: 05 Nov 2008

REFERENCES

  • G. A. Agyilirah, M. Green, R. du Cret, and G. S. Banker. (1991). Evaluation of the gastric retention properties of a cross-linked polymer coated tablet versus those of a non-disintegrating tablet. Int. J. Pharm. 75:241–247.
  • Y. Akiyama, and N. Nagahara. Novel formulation approaches to oral mucoadhesive drug delivery systemBioadhesive drug delivery systems-fundamentals, novel approaches and developmentE. Mathiowitz, D. E. Chickering, and C. M. Lehr. Marcel Dekker, Inc, New York, (1999) 477–485.
  • F. Atyabi, H. L. Sharma, and H. A. H. Mohammad. (1996a). Controlled drug release from coated floating ion exchange resin beads. J. Control Release 42:25–28.
  • F. Atyabi, H. L. Sharma, and H. A. H. Mohammad. (1996b). In vivo evaluation of a novel gastric retentive formulation based on ion exchange resin. J. Control Release 42:105–113.
  • S. S. Borodkin. Ion exchange resins and sustained releaseEncyclopedia of pharmaceutical technologyJ. Swarbrick, and J. C. Boylan. Marcel Dekker, New York, (1993) 8203–216.
  • S. Borokin, and P. Sundeberg. (1971). Polycarboxylic acid ion exchange resin absorbate for taste coverage in chewable tablet. J. Pharm. Sci. 60:1523–1527.
  • B. Chauhan, S. Shimpi, K. R. Mahadik, and A. Paradkar. (2004). Preparation and evaluation of floating risedronate sodium gelucire 39/01 matrices. Acta. Pharm. 54:205–214.
  • V. S. Chitnis, and V. S. Malshe. (1991). Bioadhesive polymer- synthesis, evaluation and application in controlled release tablets. Drug Dev. Ind. Pharm. 17:879–892.
  • G. M. Clarke, J. M. Newton, and M. B. Short. (1995). Comparative gastrointestinal transit of pellet systems of varying density. Int. J. Pharm. 114:1–11.
  • M. Cuna, and J. L. Vila. (2000). Controlled-release liquid suspension based on ion exchange resin entrapped within acrylic microcapsules. Int. J. Pharm. 199:151–158.
  • P. B. Deasy. Ion-exchange resinsMicroencapsulation and related drug processesP. B. Deasy. Marcel Dekker, New York, (1984) 241–252.
  • S. Desai, and S. Bolton. (1993). Floating controlled-release drug delivery system: In vitro-in vivo evaluation. Pharm. Res. 10:1321–1325.
  • S. J. Hwang, H. Park, and K. Park. (1998). Gastric retentive drug-delivery systems. Crit Rev. Ther. Drug. Carrier. Syst. 15:243–284.
  • W. J. Irwin, K. A. Belaid, and H. O. Alpar. (1987). Drug delivery by ion exchange. Part-III: Interaction of ester prodrugs of propranolol with cationic exchange ion exchange resin. Drug Dev. Ind. Pharm. 13:2047–2066.
  • R. Krögel & Bodmeier. (1999). Floating or pulsatile drug delivery systems based on coated effervescent cores. Int. J. Pharm. 187:175–184.
  • R. S. Langer, and N. A. Peppas. (1981). Present and future applications of biomaterials in controlled drug delivery systems. Biomaterials 2:201–214.
  • J. H. Lee, T. G. Park, and H. K. Choi. (1999). Development of oral drug delivery system using floating microspheres. J. Microencapsul. 16:715–729.
  • A. J. Moes. (1993). Gastroretentive dosage forms. Crit. Rev. Ther. Drug Carrier Syst. 10 (2):143–159.
  • S. Motycka, C. J. L. Newth, and J. G. Nairn. (1985). Preparation and evaluation of microencapsulated and coated ion-exchange resin beads containing theophylline. J. Pharm. Sci. 74:643–646.
  • Y. Pongpaibul, H. A. M. Sayed, and C. W. Whitworth. (1989). Effect of process variables on drug release from microparticles containing a drug-ion exchange resin complex. Drug Dev. Ind. Pharm. 15:2547–2558.
  • S. C. Porter, and I. Ghebre-Sellassie. Key factors in the development of modified-release pelletsMultiparticulate oral drug deliveryI. Ghebre-Sellassie. Marcel Dekker, Inc, New York, (1994) 217–284.
  • Y. L. Ragunathan, P. Amsel, O. N. Hinsvark, and W. Bryant. (1981). Sustained-release drug delivery I: Coated ion resin system for phenylpropanolamine and other drugs. J. Pharm. Sci. 70:379–384.
  • S. Sangekar, W. A. Vadino, and I. Chaudry. (1987). Evaluation of the effect of food and specific gravity of tablets on gastric retention time. Int. J. Pharm. 35:187–191.
  • S. Shimpi, B. Chauhan, K. R. Mahadik, and A. Paradkar. (2004). Preparation and evaluation of diltiazem hydrochloride-gelucire 43/01 floating granules prepared by melt granulation. AAPS Pharm. Sci. Tech 5 (3):43.
  • L. Shoufeng, L. Senshang, P. D. Bruce, L. M. Haresh, and W. C. Yie. (2002). Effect of formulation variables on the floating properties of gastric floating drug delivery system. Drug Dev. Ind. Pharm. 28:783–793.
  • B. N. Singh, and K. H. Kim. (2000). Floating drug delivery systems: approaches to oral controlled drug delivery via gastric retention. J. Control Release 63:235–259.
  • L. O. Sprockel, J. C. Prince, and R. Jennings. (1989). In-vitro/in-vivo evaluation of a liquid sustained release dosage form of chlorpheniramine. Drug Dev. Ind. Pharm. 15:1275–1287.
  • M. Sriwongjanya, and R. Bodmeier. (1998). Effect of ion exchange resin on drug release from matrix tablets. Eur. J. Pharm. Biopharm. 46:321–327.
  • A. Streubel, and R. Bodmeier. (2002). Floating microparticles based on low-density foam powder. Int. J. Pharm. 241:279–292.
  • Technical Bulletin IE-211-5/75 –, and Amberlite IRP-88 Rohm and Haas, PhiladelpiaPA, .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.